Hepatitis C prevalence in HIV-infected individuals: a comparison of inpatient and outpatient care

Abstract

Summary

Due to the shared risk factors for viral transmission, coinfection of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) is common. This study examined the seroprevalence of HCV among HIV–infected patients in inpatient and outpatient settings. A retrospective chart review of 256 HIV–infected patients was conducted in Prince George's Hospital Center (inpatients from 1 September 2011 to 1 March 2012) and Glenridge Medical Center (outpatients from 1 January 2011 to 31 December 2012). The mean age of the population was 46 ± 12 and 44 ± 11 for inpatients and outpatients, respectively. HIV–infected men comprised 61.9% inpatients and 64.8% outpatients. The overall prevalence of HCV infection in HIV/AIDS patients was 12.5% (32/256), with a higher prevalence in the inpatient group than that in the outpatient group (24.6% vs 11.2%, p < 0.01). The percentages of drug abuse (43.8% vs 16.5%, p < 0.01) and alcoholism (25.0% and 14.3%, p < 0.05) in HCV/HIV–coinfected patients were higher than those in HIV–monoinfected patients. In addition, only 64.9% of HIV–infected and 50.0% of HCV/HIV–coinfected inpatients were followed up with outside care after discharge. To our knowledge, this study, for the first time, revealed that HCV/HIV coinfection was significantly higher in inpatients compared to outpatients. Considering the high prevalence and comorbidities associated with HCV/HIV coinfection, it is recommended that evaluation of hepatic damage, especially fibrosis, should be initiated during hospitalization as well as outpatient care.

Keywords

Hepatitis C virus human immunodeficiency virus HIV AIDS prevalence coinfection outpatients inpatients

Get full access to this article

View all access options for this article.

References

Alter

. The prevalence of hepatitis C virus infection in the United States, 1988 through, 1994. New Eng J Med 1999; 341: 556–62.

Spradling

. Trends in hepatitis C virus infection among patients in the HIV Outpatient Study, 1996–2007. J Acquir Immune Defic Syndr 2010; 53: 388–396.

Koziel

Peters

. Viral hepatitis in HIV infection. New Eng J Med 2007; 356: 1445–1454.

Weber

. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Int Med 2006; 166: 1632–1641.

Allison

. Association of interleukin-15-induced peripheral immune activation with hepatic stellate cell activation in persons coinfected with hepatitis C virus and HIV. J Infect Dis 2009; 200: 619–623.

Soriano

. Update on HIV/HCV Coinfection. Curr HIV/AIDS Rep 2013; 10: 226–234.

Strader

. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004; 39: 1147–1171.

Blanco

. Mandatory HIV screening of persons aged 15–65 follows HCV testing of baby boomers. AIDS Rev 2013; 15: 134–134.

Staples

Jr Rimland

Dudas

. Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): the effect of coinfection on survival. Clin Infect Dis 1999; 29: 150–154.

10.

Sherman

. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis 2002; 34: 831–837.

11.

Rosen

. Characteristics and behaviors associated with HIV infection among inmates in the North Carolina prison system. Am J Public Health 2009; 99: 1123–1130.

12.

Soriano

. Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe. J Infect Dis 2008; 198: 1337–1344.

13.

Rossi

Volberding

Wright

. Does hepatitis C virus infection increase the risk of HIV disease progression?. JAMA 2002; 288: 241–243.

14.

Rockstroh

. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. J Infect Dis 2005; 192: 992–1002.

15.

Limketkai

. Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV. JAMA 2012; 308: 370–378.

16.

Chen

. Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression. Clin Infect Dis 2009; 49: 1605–1615.

17.

Naggie

Sulkowski

. Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals. Gastroenterology 2012; 142: 1324–1334. e3.

18.

Helleberg

. Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study. Clin Infect Dis 2013; 56: 727–734.

19.

Chuang

. Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2010; 19: 1261–1268.

20.

Wright

. Impact of lifetime alcohol quit attempts and medicated detoxifications on time to relapse during an index alcohol detoxification. J Addict Med 2007; 1: 15–20.

21.

Hutchinson

Bird

Goldberg

. Influence of alcohol on the progression of hepatitis C virus infection: a meta-analysis. Clin Gastroenterol Hepatol 2005; 3: 1150–1159.